Trial Profile

Phase 2b clinical trial of Neumifil in patients who are at high risk of viral induced exacerbations of their underlying disease, such as COPD and bronchiectasis

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 06 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jun 2023 According to a Pneumagen media release, the company announced that it has secured 8 million pounds in financing from existing and new investors to support the continued Phase 2 development of Neumifil including preparing for a Phase 2b study in Chronic Obstructive Pulmonary Disease (COPD) patients suffering from virus induced exacerbations.
18 Apr 2023 According to a Pneumagen media release, the company plans to start this study in 2024.
29 Sep 2022 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com